NEW SITE — FASTER TURNAROUND, MORE LABS. READ ON
Free peptide testing

Ordered GHK-Cu from LSPL? Mail in a sample (US only) and let us test it for free.

Test my supply
+2 more ↓
86%
Finnrick rating
#85 of 140 GHK-Cu vendors
5 of 6 classifiable tests passed
natural 83% · customers 4.0★ (2)
methodology · Purity focus
Finnrick analysis · GHK-Cu

LSPL's GHK-Cu profile is held back by fill volatility, including a +40% overfill failure, even though identity and purity were consistently clean. Batch identifiers are mostly absent, so documentation is the main next check.

methodology →
vendor intelligence report
Vendor Intelligence Report: LSPL

LSPL’s Facebook-only front end traces through ZZQ’s admin email to a Chinese IT registrant, while clone-like peptide storefronts sit on a shared IP/CMS stack. The report also documents a forum ban for incentivized reviews and COA provenance disputes.

27 pages7 risk factors assessed12 Jun 2026
read the report
Peptides
#
Peptide
$/MG
Rating
N
1
GHK-Cuselected
$0.06
86%
6
2
Tirzepatide
$0.50
77%
21
3
Ipamorelin
$0.80
68%
3
4
Retatrutide
$0.55
64%
24
5
Cagrilintide
$2.00
62%
3
6
BPC-157
$2.40
-
0
7
GLOW
$0.23
-
0
8
PT-141
-
-
0
10
TB-500
$1.50
-
0
Contact channels
Rating trend
CUMULATIVE FINNRICK RATING
83%+65%+48%+30%+<30%6 Nov 2025: 88%6 Dec 2025: 83%6 Dec 2025: 84%11 Dec 2025: 84%18 Feb 2026: 86%22 Feb 2026: 87%29 Sep 2026: current 86%88%86%Nov 25Sep 26
Showing GHK-Cu tests only
LSPL GHK-Cu test history
COA-backed lab tests

About LSPL test results from Finnrick

LSPL is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 5 peptides and 57 tests, including ratings, observed price signals, recent test dates, and correction history where available.

Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.

The most visible LSPL peptides in this dataset are Cagrilintide (3 tests), GHK-Cu (6 tests) and Ipamorelin (3 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.

Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 57 recent tests.

Corrections
No corrections.
Free peptide testing

Ordered GHK-Cu from LSPL? Mail in a sample (US only) and let us test it for free.

Test my supply